WOODROW ADAM (VP & Chief Commercial Officer) sold 3.5% of their position (17.18K shares) of PARATEK PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $166.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/8/2021ACC: 0000904454-21-000520
Officer· VP & Chief Commercial Officer
Since Oct 2018
+25.77K
Net shares
Net buyer
$166.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
42.95K acquired · 17.18K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+42.95K
Price / share
—
Trade value
—
% of position
9.6%
5/27/2021
449.02K→491.98K
Common Stock
Direct
Shares
−17.18K
Price / share
$9.70
Trade value
$166.67K
% of position
3.5%
6/4/2021
491.98K→474.80K
Total
Net shares
+25.77K
Net value
-$166.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/27/2021 | A · Award | +42.95K | — | — | 9.6% | 449.02K | 491.98K |
| Common Stock Direct | 6/4/2021 | S · Sale | −17.18K | $9.70 | $166.67K | 3.5% | 491.98K | 474.80K |
| Total | +25.77K | -$166.67K | ||||||
Derivative Transactions0
No derivative transactions reported